Search is Powered by Google
Bones / Orthopaedics News

Bisphosphonates Linked To Incapacitating Bone, Joint, and Muscle Pain - FDA Alerts

rate icon Editor's Choice
Main Category: Bones / Orthopaedics
Also Included In: Cancer / Oncology;  Regulatory Affairs / Drug Approvals;  Primary Care / General Practice
Article Date: 07 Jan 2008 - 14:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:5 stars

4.54 (26 votes)

Health Professional:5 stars

4.54 (13 votes)

Article Opinions: 1 posts

The Food and Drug Administration (FDA) is reminding doctors of the link between taking bisphosphonates and a raised risk of experiencing often incapacitating bone, joint, and/or musculoskeletal pain.

Prescribing information for all bisphosphonates already includes warnings of severe musculoskeletal pain, the FDA informs. However, this information may be overlooked by doctors, resulting in delayed diagnosis, impairment and/or pain prolongation, and the subsequent use of analgesics.

The FDA quotes the following drugs

-- Actonel
-- Actonel+Ca
-- Aredia
-- Boniva
-- Didronel
-- Fosamax
-- Fosamax+D
-- Reclast
-- Skelid
-- Zometa

The pain may be experienced either within days of taking the bisphosphonate medication, or within months, and even years. There are reports of patients experiencing total relief of symptoms immediately after stopping taking the bisphosphonate, while others who stopped experienced gradual relief. We do not know what the risk factors linked to bisphosphonate are; neither do we know what the incidence of musculoskeletal pain is (for patients takings bisphosphonates).

This severe musculoskeletal pain is different from the acute phase response which includes fever, chills, bone pain, myalgias, and arthralgias that occasionally accompanies initial administration of intravenous bisphosphonates and may happen with initial exposure to once-weekly or once-monthly doses of oral bisphosphonates - these symptoms tend to resolve within several days with continued drug use.

The FDA says a doctor who has a patient who is taking bisphosphonate and is experiencing severe musculoskeletal pain should consider stopping the drug either permanently or temporarily.

What are bisphosphonates used for?

Bisphosphonates are drugs used to treat diseases which result in weakened bones; most commonly these diseases include osteoporosis, osteopenia, or bone cancer.

http://www.fda.gov

Written by - Christian Nordqvist
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Slow Exercise Is Better For Menopausal Women Than Fast Exercise
07 Jul 2008
It's an inevitable truth: as we get older, our muscles deteriorate and we become weaker. Not only can this be an immensely frustrating change, but it can also have many other, more serious implications...


Osteoporosis and Psychology image Osteoporosis and Psychology

Understanding the psychological challenges of osteoporosis - and knowing how to cope with them - are important goals for all women with this disease. In this webcast, the emotional issues facing women with osteoporosis...

Living with Osteoporosis image Living with Osteoporosis

No picture of osteoporosis is complete without an understanding of the personal impact this disease can have. And no one can express this impact better than someone who is living with the disease. Join us as we talk to Cecilia Johnson about the physical and emotional challenges of her 15-year...

View more videos...